BBVA
UROV

Banco Bilbao Vizcaya Argentaria’s Urovant Sciences Ltd. UROV Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-101,975
Closed -$1M – 804
2020
Q2 		$1M Buy
+101,975
New +$978K 0.03% 402

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's UROV Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Urovant Sciences Ltd. (UROV) in Q3 2020, closing a stake of 101,975 shares — an estimated $1M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in UROV in Q2 2020 and held it in 1 quarter. The position peaked at $1M in Q2 2020. 23 funds tracked by Wall St. Rank hold UROV as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Urovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 101,975 Urovant Sciences Ltd. shares in Q3 2020, an estimated $1M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Urovant Sciences Ltd. in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Urovant Sciences Ltd. position peaked at $1M in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.